Antihypertensive medication |
|
|
|
Covid-19
hospitalization
in total population
|
Covid-19 hospitalization
in total
population
|
|
|
28-day mortality
in
Covid-19 patients
|
28-day
mortality
in Covid-19 patients
|
28-day mortality
in Covid-19 patients
|
|
|
|
28-day mortality
in hospitalized
Covid-19 patients
|
28-day
mortality
in hospitalized Covid-19
patients
|
|
ntotal |
ncase |
OR (95%CI) * |
OR (95%CI)
* |
OR (95%CI) * |
ntotal |
ncase |
ncase |
OR (95%CI)
* |
OR (95%CI) * |
ntotal |
ncase |
OR (95%CI) * |
OR (95%CI)
* |
OR (95%CI)
* |
|
|
|
Simple model* |
Simple
model* |
Full model† |
|
|
|
Simple model* |
Full
model† |
|
|
Simple model* |
Simple model* |
Full
model† |
ARB |
31917 |
264 |
Ref. |
Ref. |
Ref. |
1217 |
100 |
100 |
Ref. |
Ref. |
264 |
58 |
Ref. |
Ref. |
Ref. |
CCB |
44816 |
345 |
0.91 (0.78-1.07) |
0.91 (0.78-1.07) |
1.09
(0.93-1.29) |
1694 |
99 |
99 |
0.68 (0.50-0.91) |
0.74 (0.54-1.02) |
345 |
74 |
0.91 (0.61-1.36) |
0.91 (0.61-1.36) |
1.02
(0.65-1.59) |
ARB |
31917 |
264 |
Ref. |
Ref. |
Ref. |
1217 |
100 |
100 |
Ref. |
Ref. |
264 |
58 |
Ref. |
Ref. |
Ref. |
BB |
24550 |
305 |
1.45 (1.23-1.72) |
1.45 (1.23-1.72) |
1.26
(1.06-1.49) |
968 |
115 |
115 |
1.19 (0.89-1.60) |
1.07 (0.78-1.47) |
305 |
76 |
0.98 (0.65-1.47) |
0.98 (0.65-1.47) |
1.04
(0.66-1.64) |
ARB |
31917 |
264 |
Ref. |
Ref. |
Ref. |
1217 |
100 |
100 |
Ref. |
Ref. |
264 |
58 |
Ref. |
Ref. |
Ref. |
Diuretic |
23286 |
297 |
1.54 (1.31-1.83) |
1.54 (1.31-1.83) |
1.28
(1.08-1.52) |
922 |
109 |
109 |
1.26 (0.93-1.69) |
1.03 (0.75-1.42) |
297 |
76 |
1.11 (0.74-1.66) |
1.11 (0.74-1.66) |
1.05
(0.67-1.64) |
ARB |
31917 |
264 |
Ref. |
Ref. |
Ref. |
1217 |
100 |
100 |
Ref. |
Ref. |
264 |
58 |
Ref. |
Ref. |
Ref. |
CCB/BB/Diuretic |
38691 |
366 |
1.15 (0.98-1.35) |
1.15 (0.98-1.35) |
1.50 (1.27-1.77) |
1485 |
137 |
137 |
1.06 (0.80-1.41) |
1.18
(0.87-1.59) |
366 |
90 |
1.06 (0.72-1.56) |
1.06 (0.72-1.56) |
1.25
(0.80-1.94) |